Sexual health
PT-141
Bremelanotide · Vyleesi · melanocortin
A melanocortin peptide for sexual desire — the active ingredient is a licensed medicine (Vyleesi) in some markets, but research-grade 'PT-141' is a different lane.
Reference status
Editorial research · independent review pending · 3 claims graded
What it is
PT-141 (bremelanotide) acts on melanocortin receptors in the brain to influence sexual arousal, rather than on blood flow like the more familiar ED drugs. As bremelanotide (brand Vyleesi) it is an approved medicine for a specific condition in some countries.
The version sold by research suppliers is not the regulated product. We separate the licensed medicine from the grey-market research chemical, because the safety and legal picture is completely different.
The science, graded
What’s claimed — and how strong the evidence behind each claim actually is.
“Increases sexual desire”
As licensed bremelanotide, RCTs support a modest effect for a specific indication (HSDD in women).
Claim-level citation mapping is in progress.
“Works for general libido enhancement in anyone”
Broad community use is off-label/experimental and not what the trials tested.
Claim-level citation mapping is in progress.
“Side-effect free”
Nausea and transient blood-pressure changes are documented; not side-effect free.
Claim-level citation mapping is in progress.
Legal and regulatory context
Separate summaries for Great Britain, the United States, and the European Union. These are preliminary research summaries awaiting independent regional review; they are not legal determinations or advice.
Great Britain
Bremelanotide is a regulated medicine in some markets. In the UK it is not a general consumer product; research-grade 'PT-141' is sold as a research chemical and is not a legal human-use supplement.
This is preliminary regulatory research, not a reviewed legal determination or legal advice.
United States
Regional legal and regulatory review required before publication.
This is preliminary regulatory research, not a reviewed legal determination or legal advice.
- FDA's Concerns About Unapproved Drugs · U.S. Food and Drug Administration
European Union
Regional legal and regulatory review required before publication.
This is preliminary regulatory research, not a reviewed legal determination or legal advice.
- Buying medicines online · European Medicines Agency
What the community says
Discussed for libido across mixed communities. Users note nausea and the need to time dosing; effectiveness reports vary widely.
Where they’re talking
- r/PeptidesDose-finding and nausea threads.
- Health forumsComparisons with conventional ED treatment.
References
- 1.Supply unlicensed medicinal products (specials) · MHRA
- 2.FDA's Concerns About Unapproved Drugs · U.S. Food and Drug Administration
- 3.Buying medicines online · European Medicines Agency